June 8th was the 5th Redefining Early Stage Investments (RESI) conference, and the first at Houston’s Texas Medical Center’s Innovation Portal (TMCx). Throughout the day in several conference rooms, panels and workshops provided platforms for investors to communicate directly to fundraising entrepreneurs. Topics covered included biotech angels and venture philanthropy. The event offered firsthand accounts from investors explaining their current investment mandates and procedures for identifying and qualifying candidates.
LSN’s CEO Dennis Ford comments, “It can be overwhelming and we absolutely love that aspect. We want to give everyone who comes here more opportunities than they can make a decision about, because if we’re doing that, we’re doing our job. We really want to inundate everyone, for one day, and submerge them in this early stage investor world to let them get a lot of bang for their buck instead of stretching it out over a period of several days. We want to give them as much value as possible.”
RESI@TMCx provided the platform for early stage investors and life science entrepreneurs to make a compelling connection, and is a result of partnerships between Life Science Nation, Texas Medical Center, Johnson & Johnson Innovation, and JLABS (JLABS @TMC).
Those who missed the Houston event will have only 90 days to wait until RESI comes to Boston on September 16 at the Westin, Copley. For now, the RESI conferences are limited to 3/year (Boston-Fall, San Francisco-Winter, Houston-Spring/Summer). As interest and attendance continue to grow, so too will RESI’s frequency and geographic footprint.
RESI BOSTON Now Open for Registration
Registration (with early bird pricing) is now available for RESI Boston (September):